Qinghua Zhou Selected Research

mesoglycan

1/2020	Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer: A systematic review.
12/2017	The utility of 18F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer: a PRISMA-compliant meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinghua Zhou Research Topics

Disease

139	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2002
130	Neoplasms (Cancer) 05/2024 - 02/2002
86	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 08/2002
58	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2002
23	Adenocarcinoma of Lung 01/2024 - 04/2002
22	Carcinogenesis 01/2020 - 02/2002
9	Carcinoma (Carcinomatosis) 01/2021 - 04/2002
8	Adenocarcinoma 12/2021 - 04/2004
8	Prostatic Neoplasms (Prostate Cancer) 03/2013 - 04/2006
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 04/2004
4	Inflammation (Inflammations) 05/2024 - 04/2011
4	Lung Diseases (Lung Disease) 01/2024 - 02/2004
4	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2006
3	Circulating Neoplastic Cells 12/2023 - 11/2012
3	Disease Progression 07/2023 - 01/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 04/2004
3	Wounds and Injuries (Trauma) 11/2022 - 12/2019
3	Lymphatic Metastasis 01/2022 - 04/2004
3	Liver Neoplasms (Liver Cancer) 01/2021 - 04/2006
3	Malignant Pleural Effusion 02/2019 - 10/2004
3	Exanthema (Rash) 08/2011 - 08/2004
2	Malignant Mesothelioma 05/2024 - 10/2023
2	Pneumonia (Pneumonitis) 01/2024 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2019
2	Non-alcoholic Fatty Liver Disease 10/2023 - 10/2021
2	Lewis Lung Carcinoma 01/2023 - 04/2004
2	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 11/2009
2	Obesity 12/2021 - 06/2019
2	Hepatocellular Carcinoma (Hepatoma) 07/2021 - 12/2009

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2004
20	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2008
16	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2010
15	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2002
14	Messenger RNA (mRNA)IBA 05/2024 - 04/2004
14	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2009
12	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2009
10	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
9	CateninsIBA 01/2018 - 08/2002
8	Cadherins (E-Cadherin)IBA 09/2017 - 08/2002
7	Phosphotransferases (Kinase)IBA 08/2017 - 02/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2002
6	Gefitinib (Iressa)FDA Link 11/2022 - 08/2004
6	EnzymesIBA 01/2021 - 02/2005
5	CytokinesIBA 01/2023 - 03/2009
5	SmokeIBA 01/2023 - 04/2005
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 02/2005
5	Small Interfering RNA (siRNA)IBA 01/2017 - 05/2010
5	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2010 - 02/2002
4	LigandsIBA 01/2024 - 01/2018
4	Monoclonal AntibodiesIBA 01/2024 - 10/2006
4	ParaffinIBA 10/2023 - 08/2008
4	CarcinogensIBA 08/2022 - 06/2010
4	Long Noncoding RNAIBA 01/2021 - 01/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 02/2004
4	Nicotine FDA Link 04/2016 - 09/2011
4	Transcription Factors (Transcription Factor)IBA 04/2013 - 11/2009
4	SeleniumIBA 04/2012 - 04/2006
4	methylselenic acidIBA 04/2012 - 04/2006
4	EndostatinsIBA 08/2005 - 12/2002
3	B7-H1 AntigenIBA 03/2024 - 01/2022
3	AntibodiesIBA 01/2024 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2014
3	Formaldehyde (Formol)FDA Link 01/2023 - 08/2008
3	Complementary DNA (cDNA)IBA 01/2022 - 06/2005
3	AntigensIBA 01/2022 - 01/2011
3	Interleukin-6 (Interleukin 6)IBA 09/2017 - 08/2010
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2017 - 10/2010
3	LuciferasesIBA 06/2016 - 12/2004
3	Therapeutic UsesIBA 03/2016 - 10/2008
3	AndrogensIBA 03/2012 - 08/2010
3	Androgen Receptors (Androgen Receptor)IBA 02/2011 - 04/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2010 - 12/2009
3	calphostin CIBA 06/2008 - 04/2004
3	tanshinoneIBA 04/2008 - 04/2002
3	hnRNP A2IBA 10/2006 - 04/2004
3	VaccinesIBA 01/2005 - 08/2002
3	Protein Kinases (Protein Kinase)IBA 10/2004 - 02/2004
2	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2024 - 07/2023
2	LipidsIBA 10/2023 - 10/2021
2	Liposomes (Liposome)IBA 01/2023 - 10/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2022 - 06/2011
2	Immunologic Factors (Immunomodulators)IBA 12/2021 - 01/2018
2	Coloring Agents (Dyes)IBA 12/2021 - 10/2009
2	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2017

Therapy/Procedure

46	Therapeutics 01/2024 - 12/2002
27	Drug Therapy (Chemotherapy) 01/2024 - 08/2002
18	Immunotherapy 05/2024 - 11/2018
11	Thoracotomy 11/2022 - 03/2010
8	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 05/2018
8	Radiotherapy 01/2023 - 08/2004
6	Neoadjuvant Therapy 07/2023 - 10/2009
6	Segmental Mastectomy (Lumpectomy) 01/2023 - 03/2019
6	Castration 03/2013 - 03/2010
3	Adjuvant Chemotherapy 01/2022 - 01/2013
3	Aftercare (After-Treatment) 03/2010 - 04/2004
2	Chemoprevention 11/2021 - 07/2011
2	Ligation 07/2021 - 12/2019
2	Contraindications 01/2021 - 02/2006
2	Transplantation 01/2021 - 08/2010